Американское общество гирудотерапии

Anticoagulation during ECMO in neonatal and paediatric patients.

Review published in Thrombosis research (2018)

Последнее обновление: June 18, 2026Рецензент: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Narrative reviewКлинические исследованияРазработка лекарственных препаратовBarton et al. · Thrombosis research, 2018

Abstract

Extracorporeal Membrane Oxygenation (ECMO) is a form of Extracorporeal Life Support (ECLS) which is used frequently in the paediatric and neonatal setting to support either the pulmonary, or both the pulmonary and cardiac systems. Management of ECMO requires the use of systemic anticoagulation to prevent patient and circuit based thrombosis, which in turn increases the risk of haemorrhage. A number of coagulation tests, laboratory and point of care based, are used to monitor anticoagulation, however the evidence for correlation of the test results with level of anticoagulant and clinical outcomes in children remains poor.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal ArticleReview
Indexed MeSH termsAnticoagulantsBlood Coagulation TestsChildDrug MonitoringExtracorporeal Membrane OxygenationHemorrhageHemostasisHumansInfantThrombosis

Резюме

Extracorporeal Membrane Oxygenation (ECMO) is a form of Extracorporeal Life Support (ECLS) which is used frequently in the paediatric and neonatal setting to support either the pulmonary, or both the pulmonary and cardiac systems. Management of ECMO requires the use of systemic anticoagulation to...

Почему это важно для гирудотерапии

This review discussed the use of systemic anticoagulation and the challenges of monitoring its therapeutic effects during extracorporeal membrane oxygenation in pediatric and neonatal patients, noting that evidence for correlation between coagulation test results and clinical outcomes in children remains poor. The abstract addresses the clinical tension between preventing thrombosis and increasing hemorrhage risk in this critical care setting. It does not mention leeches, hirudotherapy, hirudin, or any leech-derived substances. Based solely on this abstract, there is no defensible connection to ASH's domain.

Цитирование

Anticoagulation during ECMO in neonatal and paediatric patients.

Barton et al. · Thrombosis research, 2018

Связанный клинический контекст

Добавлено в библиотеку ASH: May 28, 2026 · Последнее обновление сайта: June 18, 2026

Этот сайт предоставляет образовательную информацию и не является медицинской консультацией, диагнозом или рекомендацией по лечению. Гирудотерапия сопряжена с клинически значимыми рисками и должна проводиться только квалифицированными клиницистами в рамках институционально утверждённых протоколов. Разрешение FDA 510(k) для медицинских пиявок ограничено определёнными показаниями; обсуждения исследовательского и нелицензионного применения отмечены соответствующим образом. Для индивидуальных медицинских рекомендаций обратитесь к квалифицированному медицинскому специалисту.